Live feed
Filing
SC 13D/A
SC 13D/A0001193125-24-114056·Fairmount Funds Management LLC
Schedule 13D ownership disclosure
Spyre Therapeutics Inc
Security class unavailable · CUSIP: 00773J202
Event date: 2024-04-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-114056
- Form type
- SC 13D/A
- Filer
- Fairmount Funds Management LLC
- CIK
- CIK 1802528
- Filed
- Apr 25, 2024
- Reporting period
- Apr 23, 2024
- Description
- Schedule 13D beneficial ownership